Rockwell Medical Submits Additional Data For IND Application For Iron Deficiency Candidate

  • Rockwell Medical Inc RMTI has provided the FDA with the supplemental data requested by the agency in December 2021 for its pending Investigational New Drug (IND) application of Ferric Pyrophosphate Citrate (FPC) for iron deficiency.
  • The IND supports the proposed Phase 2 trial of FPC for treating iron deficiency anemia and maintaining hemoglobin in patients receiving infusion therapy in the home setting.
  • The additional data relate to the physical, chemical, and microbiological stability of FPC in support of the suggested method of administration in the Phase 2 protocol.
  • Also Read: Why Are Rockwell Medical Shares Surging Wednesday?
  • The FDA has 30 days to review the additional data. The company would expect the trial to start shortly after the review period ends.
  • Separately, Rockwell Medical announced a 1-for-11 reverse split effective at 12:01 a.m. Eastern Time on May 13.
  • At Rockwell's Annual Meeting of Stockholders held on May 9, the company's stockholders approved the Reverse Stock Split ratio of not less than 1-for-2 and not more than 1-for-15.
  • Price Action: RMTI shares are down 33.40% at $0.21 during the market session on the last check Thursday.

Posted In: BriefsBiotechNewsPenny StocksHealth CareFDAStock SplitMoversTrading IdeasGeneral

Ad Disclosure: The rate information is obtained by Bankrate from the listed institutions. Bankrate cannot guaranty the accuracy or availability of any rates shown above. Institutions may have different rates on their own websites than those posted on Bankrate.com. The listings that appear on this page are from companies from which this website receives compensation, which may impact how, where, and in what order products appear. This table does not include all companies or all available products.

All rates are subject to change without notice and may vary depending on location. These quotes are from banks, thrifts, and credit unions, some of whom have paid for a link to their own Web site where you can find additional information. Those with a paid link are our Advertisers. Those without a paid link are listings we obtain to improve the consumer shopping experience and are not Advertisers. To receive the Bankrate.com rate from an Advertiser, please identify yourself as a Bankrate customer. Bank and thrift deposits are insured by the Federal Deposit Insurance Corp. Credit union deposits are insured by the National Credit Union Administration.

Consumer Satisfaction: Bankrate attempts to verify the accuracy and availability of its Advertisers' terms through its quality assurance process and requires Advertisers to agree to our Terms and Conditions and to adhere to our Quality Control Program. If you believe that you have received an inaccurate quote or are otherwise not satisfied with the services provided to you by the institution you choose, please click here.

Rate collection and criteria: Click here for more information on rate collection and criteria.